PMVP Research and Charts

PMVP - PMV Pharmaceuticals Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-07-11)

Last 1.26	Change ⇓ -0.01 (-0.79%)	Volume 101,318
	Open 1.25	High 1.28	Low 1.23

8EMA (Daily) 1.22	40EMA (Daily) 1.09	50EMA (Daily) 1.08	STO (Daily) 85.000	MACD Hist (Daily) 0.037
8EMA (Weekly) 1.106	40EMA (Weekly) 1.31	50EMA (Weekly) 1.46	STO (Weekly) 68.397	MACD Hist (Weekly) 0.108


Company Profile
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.